Image via PRN — Economy & Policy
Last updated
Abbott: Ma Activity
Abbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Source: PRN — Economy & Policy
The leadership read
Consolidation shifts the leadership question from growth to integration. For Abbott in MedTech, the demand moves toward transformation and integration leaders who can merge teams, systems and cultures without losing momentum. Across Americas, watch whether the integration is properly resourced; deals are won or lost the year after they close.
Market context: Backdrop: a 105.8 (Hot) Talent Market Index (down 2.3 on the month) with Americas activity rising (+2.4pts).
Abbott: 1 signal in the last 90 days — in line with the MedTech median of 1 across 20 tracked companies; 0.2% of MitchelLake's Americas signal flow; 5 tracked across 83 days.
Also at Abbott →
More signals across MedTech
Ma Activity · Americas
Medtronic →Medtronic completed acquisition of SPR Therapeutics for $650M cash. SPR specializes in FDA-cleared short-term peripheral nerve stimulation (PNS) therapy for chronic and acute pain. Deal adds SPRINT PNS System to Medtronic's neuromodulation portfolio.
Ma Activity · Americas
Analog Devices →Analog Devices completed acquisition of Empower Semiconductor to strengthen its position as a power partner across the AI ecosystem
Ma Activity · Americas
Boston Scientific →Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Ma Activity · Americas
McKesson →McKesson planning medical-surgical spinoff and share buyback program, indicating major portfolio restructuring
Ma Activity · Americas
QuidelOrtho Corporation →QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes
Intelligence powered by Autonodal ↗